EU Probes Novo Nordisk Drugs After Reports of Suicidal Thoughts

Published on July 10, 2023
The European Medicines Agency (EMA) is probing Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator